Oregon § 459A.203 Requirement to participate in drug take-back program; rules; fines

Oregon Statutes

§ 459A.203 — Requirement to participate in drug take-back program; rules; fines

Oregon § 459A.203

Vol.13

Title 36AHousing; Lottery and Games; Environment

Ch. 459AReuse and Recycling

This text of Oregon § 459A.203 (Requirement to participate in drug take-back program; rules; fines) is published on Counsel Stack Legal Research, covering Oregon primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Or. Rev. Stat. § 459A.203 (2026).

Text

(1)Except as provided in subsection (2) of this section, each covered manufacturer shall participate in a drug take-back program that complies with the requirements of ORS 459A.200 to 459A.266. A covered manufacturer may participate in a drug take-back program independently, as part of a group of covered manufacturers or by delegating the covered manufacturer’s duties under ORS 459A.200 to 459A.266 to a drug take-back organization.

(2)(a) A covered manufacturer is not required to participate in a drug take-back program as described in subsection (1) of this section if the covered manufacturer provides sufficient proof to the Department of Environmental Quality that the covered manufacturer manufactures covered drugs for fewer than 50 patients in this state.

(b)The Environmental Quality C

Free access — add to your briefcase to read the full text and ask questions with AI

(1) Except as provided in subsection (2) of this section, each covered manufacturer shall participate in a drug take-back program that complies with the requirements of ORS 459A.200 to 459A.266. A covered manufacturer may participate in a drug take-back program independently, as part of a group of covered manufacturers or by delegating the covered manufacturer’s duties under ORS 459A.200 to 459A.266 to a drug take-back organization.
(2)(a) A covered manufacturer is not required to participate in a drug take-back program as described in subsection (1) of this section if the covered manufacturer provides sufficient proof to the Department of Environmental Quality that the covered manufacturer manufactures covered drugs for fewer than 50 patients in this state.
(b) The Environmental Quality Commission may adopt rules regarding this subsection.
(3) If a covered manufacturer does not participate in a drug take-back program as described in subsection (1) of this section, and does not qualify for exemption under subsection (2) of this section, the State Board of Pharmacy may assess a fine against the covered manufacturer in an amount not to exceed $10,000 for each day that covered drugs manufactured by the covered manufacturer are sold in this state.